US equities
|
AAPL
$331.90
▼-1.90%
NVDA
$206.69
▲+2.29%
MU
$855.10
▲+2.58%
AMD
$483.90
▲+3.65%
ORCL
$126.19
▲+5.85%
TSLA
$398.50
▼-1.32%
MSFT
$520.99
▲+2.74%
SPCX
$141.31
▲+3.62%
AAPL
$331.90
▼-1.90%
NVDA
$206.69
▲+2.29%
MU
$855.10
▲+2.58%
AMD
$483.90
▲+3.65%
ORCL
$126.19
▲+5.85%
TSLA
$398.50
▼-1.32%
MSFT
$520.99
▲+2.74%
SPCX
$141.31
▲+3.62%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
OraSure Technologies, Inc. - Common Stock
(NQ:
OSUR
)
3.530
+0.075 (+2.17%)
Delayed Quote
Updated: 4:00 PM EST, Nov 3, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about OraSure Technologies, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Cramer Weighs In On Johnson & Johnson, ViacomCBS And More
↗
June 15, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer said Johnson & Johnson (NYSE: JNJ) goes up no matter what because it has a big drug pipeline. He would own the...
Via
Benzinga
OraSure's COVID-19 Rapid Antigen Tests Gets FDA Emergency Approval for OTC, Professional, Prescription Use
↗
June 07, 2021
OraSure Technologies Inc (NASDAQ: OSUR) has received FDA Emergency Use Authorization (EUA) for its COVID-19 rapid antigen tests, InteliSwab. These tests detect...
Via
Benzinga
OraSure Resubmits EUA Applications for ELISA COVID-19 Antibody Test
↗
May 26, 2021
OraSure Technologies Inc (NASDAQ: OSUR) has resubmitted two separate Emergency Use Authorization (EUA) applications for its SARS-CoV-2 Antibody ELISA and the oral specimen...
Via
Benzinga
Orasure Technologies Inc (OSUR) Q1 2021 Earnings Call Transcript
↗
May 06, 2021
OSUR earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Stocks That Hit 52-Week Lows On Friday
↗
April 30, 2021
Friday morning saw 14 companies set new 52-week lows. Points of Interest: Lufax Holding (NYSE:LU) was the largest, in terms of market cap, to set a new 52-week low...
Via
Benzinga
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs
↗
May 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...
Via
Benzinga
Earnings Scheduled For May 5, 2021
↗
May 05, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom
↗
May 06, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
↗
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
↗
April 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
April 20, 2021
Tuesday's morning session saw 33 companies set new 52-week lows. Highlights: The largest company by market cap to set a new 52-week low was iQIYI (NASDAQ:IQ)....
Via
Benzinga
The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue
↗
April 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 20) Alexion Pharmaceuticals,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
